Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis

T. Kawada, T. Yanagisawa, K. Bekku, E. Laukhtina, MV. Deimling, M. Majdoub, M. Chlosta, B. Pradere, M. Babjuk, P. Gontero, M. Moschini, M. Araki, SF. Shariat

. 2023 ; 15 (12) : 933-943. [pub] 20230706

Language English Country England, Great Britain

Document type Meta-Analysis, Systematic Review, Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc23016672

Aim: We aimed to review the evidence of reducing the dose or number of BCG instillations in non-muscle invasive bladder cancer (NMIBC) patients. Material & methods: A literature search was done according to Preferred Reporting Items for Meta-Analyses statement. Results: Overall, 15 and 13 studies were eligible for qualitative and quantitative synthesis, respectively. In patients with NMIBC, lowering either the dose or number of BCG instillations increases the risk of recurrence, but not the risk of progression. Lowering the dose of BCG decreases the risk of adverse events compared with standard-dose BCG. Conclusion: Standard-dose and -number of BCG is preferred for NMIBC patients based on oncologic efficacy; however, low-dose BCG could be considered in selected patients who suffer from significant adverse events.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016672
003      
CZ-PrNML
005      
20231026105632.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/imt-2022-0309 $2 doi
035    __
$a (PubMed)37409426
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kawada, Tatsushi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan $1 https://orcid.org/0000000283699712
245    10
$a Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis / $c T. Kawada, T. Yanagisawa, K. Bekku, E. Laukhtina, MV. Deimling, M. Majdoub, M. Chlosta, B. Pradere, M. Babjuk, P. Gontero, M. Moschini, M. Araki, SF. Shariat
520    9_
$a Aim: We aimed to review the evidence of reducing the dose or number of BCG instillations in non-muscle invasive bladder cancer (NMIBC) patients. Material & methods: A literature search was done according to Preferred Reporting Items for Meta-Analyses statement. Results: Overall, 15 and 13 studies were eligible for qualitative and quantitative synthesis, respectively. In patients with NMIBC, lowering either the dose or number of BCG instillations increases the risk of recurrence, but not the risk of progression. Lowering the dose of BCG decreases the risk of adverse events compared with standard-dose BCG. Conclusion: Standard-dose and -number of BCG is preferred for NMIBC patients based on oncologic efficacy; however, low-dose BCG could be considered in selected patients who suffer from significant adverse events.
650    _2
$a lidé $7 D006801
650    _2
$a BCG vakcína $x terapeutické užití $7 D001500
650    _2
$a adjuvancia imunologická $x terapeutické užití $7 D000276
650    12
$a nádory močového měchýře neinvadující svalovinu $7 D000093284
650    _2
$a aplikace intravezikální $7 D000283
650    12
$a nádory močového měchýře $x farmakoterapie $7 D001749
650    _2
$a lokální recidiva nádoru $7 D009364
655    _2
$a metaanalýza $7 D017418
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Yanagisawa, Takafumi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8471, Japan $1 https://orcid.org/0000000274100712
700    1_
$a Bekku, Kensuke $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan $1 https://orcid.org/0000000300021592
700    1_
$a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia $1 https://orcid.org/0000000289530272
700    1_
$a Deimling, Markus von $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany $1 https://orcid.org/0000000299543413
700    1_
$a Majdoub, Mohammed $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, Hillel Yaffe Medical Center, Hadera, 3820302, Israel
700    1_
$a Chlosta, Marcin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, Jagiellonian University Medical College, Cracow, 31-008, Poland $1 https://orcid.org/0000000308602770
700    1_
$a Pradere, Benjamin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, 31130, France $1 https://orcid.org/0000000277688558
700    1_
$a Babjuk, Marko $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Department of Urology, Second Faculty of Medicine of Charles University, University Hospital Motol, Prague, 150 06, Czech Republic
700    1_
$a Gontero, Paolo $u Urology Unit, Department of Surgical Sciences, University of Turin, Turin, 10124, Italy $1 https://orcid.org/0000000297146596
700    1_
$a Moschini, Marco $u Department of Urology, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, 20132, Italy $1 https://orcid.org/0000000230842458
700    1_
$a Araki, Motoo $u Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan $1 https://orcid.org/0000000231722482
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria $u Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia $u Division of Urology, Department of Special Surgery, The University of Jordan, Amman, 11942, Jordan $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, 150 06, Czech Republic $u Department of Urology, Weill Cornell Medical College, New York, NY 1300, USA $u Karl Landsteiner Institute of Urology & Andrology, Vienna, 1090, Austria $1 https://orcid.org/0000000266276179
773    0_
$w MED00175821 $t Immunotherapy $x 1750-7448 $g Roč. 15, č. 12 (2023), s. 933-943
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37409426 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105627 $b ABA008
999    __
$a ok $b bmc $g 2000284 $s 1203034
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 15 $c 12 $d 933-943 $e 20230706 $i 1750-7448 $m Immunotherapy $n Immunotherapy $x MED00175821
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Archiving options